RT Journal Article
SR Electronic
T1 Effects of Covid-19 on the human central olfactory system: a natural pre-post experiment
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.27.21268455
DO 10.1101/2021.12.27.21268455
A1 Thunell, Evelina
A1 Peter, Moa G.
A1 Lenoir, Vincent
A1 Andersson, Patrik
A1 Landis, Basile N.
A1 Becker, Minerva
A1 Lundström, Johan N.
YR 2021
UL http://medrxiv.org/content/early/2021/12/29/2021.12.27.21268455.abstract
AB Reduced olfactory function is the symptom with the highest prevalence in COVID-19 with nearly 70% of individuals with COVID-19 experiencing partial or total loss of their sense of smell at some point during the disease. The exact cause is not known but beyond peripheral damage, studies have demonstrated insults to both the olfactory bulb and central olfactory brain areas. However, these studies often lack both baseline pre-COVID-19 assessments and a control group and could therefore simply reflect preexisting risk factors. Right before the COVID-19 outbreak, we completed an olfactory focused study including structural MR brain images and a full clinical olfactory test. Opportunistically, we invited participants back one year later, including 9 participants who had experienced mild to medium COVID-19 (C19+) and 12 that had not (C19-), thereby creating a pre-post controlled natural experiment with a control group. Despite C19+ participants reporting subjective olfactory dysfunction, few showed signs of objectively altered function one year later. Critically, all but one individual in the C19+ group had reduced olfactory bulb volume with an average volume reduction of 14.3%, but this did not amount to a significant between group difference compared to the control group (2.3% reduction) using inference statistics. No morphological differences in cerebral olfactory areas were found but we found stronger functional connectivity between olfactory brain areas in the C19+ croup at the post measure. Taken together, these data suggest that COVID-19 might cause a long-term reduction in olfactory bulb volume but with no discernible differences in cerebral olfactory regions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding provided by the Knut and Alice Wallenberg Foundation (KAW 2018.0152) and the Swedish Research Council (2021-06527), awarded to JNL. Data acquisition supported by a grant to the Stockholm University Brain Imaging Centre (SU FV-5.1.2-1035-15).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Swedish Ethical Review Authority.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at www.osf.io https://osf.io/9fcr6/